IBDEI19K ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22392,0)
 ;;=782.0^^125^1392^87
 ;;^UTILITY(U,$J,358.3,22392,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22392,1,4,0)
 ;;=4^782.0
 ;;^UTILITY(U,$J,358.3,22392,1,5,0)
 ;;=5^Parasthesia
 ;;^UTILITY(U,$J,358.3,22392,2)
 ;;=Parasthesia^35757
 ;;^UTILITY(U,$J,358.3,22393,0)
 ;;=435.9^^125^1392^107
 ;;^UTILITY(U,$J,358.3,22393,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22393,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,22393,1,5,0)
 ;;=5^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,22393,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,22394,0)
 ;;=354.2^^125^1392^109
 ;;^UTILITY(U,$J,358.3,22394,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22394,1,4,0)
 ;;=4^354.2
 ;;^UTILITY(U,$J,358.3,22394,1,5,0)
 ;;=5^Ulnar Nerve Entrapment
 ;;^UTILITY(U,$J,358.3,22394,2)
 ;;=^268506
 ;;^UTILITY(U,$J,358.3,22395,0)
 ;;=729.1^^125^1392^35
 ;;^UTILITY(U,$J,358.3,22395,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22395,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,22395,1,5,0)
 ;;=5^Fibromyalgia
 ;;^UTILITY(U,$J,358.3,22395,2)
 ;;=Fibromyalgia^80160
 ;;^UTILITY(U,$J,358.3,22396,0)
 ;;=438.20^^125^1392^11
 ;;^UTILITY(U,$J,358.3,22396,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22396,1,4,0)
 ;;=4^438.20
 ;;^UTILITY(U,$J,358.3,22396,1,5,0)
 ;;=5^CVA w/Hemiplegia (late effect)
 ;;^UTILITY(U,$J,358.3,22396,2)
 ;;=CVA w/Hemiplegia^317910
 ;;^UTILITY(U,$J,358.3,22397,0)
 ;;=438.12^^125^1392^8
 ;;^UTILITY(U,$J,358.3,22397,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22397,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,22397,1,5,0)
 ;;=5^CVA w/Dysphasia (late effect)
 ;;^UTILITY(U,$J,358.3,22397,2)
 ;;=Stroke w/Dysphasia^317908
 ;;^UTILITY(U,$J,358.3,22398,0)
 ;;=356.8^^125^1392^90
 ;;^UTILITY(U,$J,358.3,22398,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22398,1,4,0)
 ;;=4^356.8
 ;;^UTILITY(U,$J,358.3,22398,1,5,0)
 ;;=5^Peripheral Neuropathy, Idiopathic
 ;;^UTILITY(U,$J,358.3,22398,2)
 ;;=Peripheral Neuropathy, Idio^268525
 ;;^UTILITY(U,$J,358.3,22399,0)
 ;;=337.20^^125^1392^100
 ;;^UTILITY(U,$J,358.3,22399,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22399,1,4,0)
 ;;=4^337.20
 ;;^UTILITY(U,$J,358.3,22399,1,5,0)
 ;;=5^Reflexive Sympathetic Dystrophy
 ;;^UTILITY(U,$J,358.3,22399,2)
 ;;=Reflexive Sympathetic Dystrophy^295799
 ;;^UTILITY(U,$J,358.3,22400,0)
 ;;=294.8^^125^1392^33
 ;;^UTILITY(U,$J,358.3,22400,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22400,1,4,0)
 ;;=4^294.8
 ;;^UTILITY(U,$J,358.3,22400,1,5,0)
 ;;=5^Dementia, Other
 ;;^UTILITY(U,$J,358.3,22400,2)
 ;;=^268044
 ;;^UTILITY(U,$J,358.3,22401,0)
 ;;=438.6^^125^1392^7
 ;;^UTILITY(U,$J,358.3,22401,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22401,1,4,0)
 ;;=4^438.6
 ;;^UTILITY(U,$J,358.3,22401,1,5,0)
 ;;=5^CVA w/Dysesthesia (late effect)
 ;;^UTILITY(U,$J,358.3,22401,2)
 ;;=CVA w/Dysesthesia (late effect)^328503
 ;;^UTILITY(U,$J,358.3,22402,0)
 ;;=438.7^^125^1392^26
 ;;^UTILITY(U,$J,358.3,22402,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22402,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,22402,1,5,0)
 ;;=5^CVA w/Vision Changes (late effect)
 ;;^UTILITY(U,$J,358.3,22402,2)
 ;;=CVA w/Vision Changes (late effect)^328504
 ;;^UTILITY(U,$J,358.3,22403,0)
 ;;=438.84^^125^1392^5
 ;;^UTILITY(U,$J,358.3,22403,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22403,1,4,0)
 ;;=4^438.84
 ;;^UTILITY(U,$J,358.3,22403,1,5,0)
 ;;=5^CVA w/Ataxia (late effect)
 ;;^UTILITY(U,$J,358.3,22403,2)
 ;;=CVA w/Ataxia (late effect)^328507
 ;;^UTILITY(U,$J,358.3,22404,0)
 ;;=434.91^^125^1392^27
 ;;^UTILITY(U,$J,358.3,22404,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22404,1,4,0)
 ;;=4^434.91
